Dysregulated Epigenetics of Chordoma: Prognostic Markers and Therapeutic Targets

Abstract excerpt

Chordoma is a rare, slow-growing sarcoma that is locally aggressive and typically resistant to conventional chemo- and radiotherapies. Despite its low incidence, chordoma remains a clinical challenge because therapeutic options for chordoma are limited, and little is known about the molecular mechanisms involved in resistance to therapies. Furthermore, there are currently no established predictive or prognostic...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Bone Tumor Diagnosis and Treatments
• Share to Cancer-related molecular mechanisms research
• Share to Sarcoma Diagnosis and Treatment